First-line Treatment with Empagliflozin and Metformin Combination Versus Standard Care for Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease in Qatar. A Cost-Effectiveness Analysis

Author:

Abushanab Dina,Al-Badriyeh Daoud,Liew Danny,Ademi Zanfina

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference38 articles.

1. International Diabetes Federation. IDF Diabetes Atlas. Eighth edition 2017. Available at: https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/134-idf-diabetes-atlas-8th-edition.html. Accessed 14 March 2020.

2. Projections of global mortality and burden of disease from 2002 to 2030;Mathers;PLoS Med,2006

3. BIG HEARTS BRILIANT MINDS. Impact report 2018. Available at: https://baker.edu.au/-/media/documents/who-we-are/corporate-reports/baker-institute-impact-report-2018.pdf. Accessed 20 June 2020.

4. Predictions burden of diabetes and economics cost: contributing risk factors of changing disease prevalence and its pandemic impact to qatar;Bener;Exp Clin Endocrinol Diabetes,2016

5. Innovative Approaches to Prevention Tackling the Global Burden of Cardiovascular Disease. Report of the WISH Cardiovascular Disease Forum 2016. Available at: https://www.wish.org.qa/wp-content/uploads/2018/01/IMPJ4495_WISH_CArdio_Disease_181116_WEB.pdf. Accessed 20 June 2020.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3